Photo of Phillip Gould
  • Source: Scopus
  • Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Virology, gene regulation particularly focussing on protein translation and commercialisation of science


Dr Phillip Gould’s is Associate Head of School (Enterprise and Innovation) and his research interests is based around the molecular characterisation of respiratory viruses. This includes targeting key host and viral proteins with novel therapeutics synthesised by Dr Andrew Marsh (Chemistry Department Warwick University).  Phil is also founder and CSO of OVO Biotherapeutics which is a newly formed spin out company from Coventry University. OVO Biotherapeutics have developed a platform technology that supports viral vaccine companies to generate increased manufacturing yields in faster timescales. OVO is currently being funded through a combination of enterprise grants and venture capitalist funds. Within this research community is Dr William Collier who now works for OVO and 3 PhD students. With the addition of new funds OVO is currently recruiting two additional postdoctoral scientists including a specialised bioinformatician.

Based around the current COVID-19 pandemic Phil is also involved in a number of collaborative projects with Engineering (Coventry University) and external companies looking at anti-viral surfaces.

Education/Academic qualification



Dive into the research topics where Phillip Gould is active. These topic labels come from the works of this person. Together they form a unique fingerprint.


Recent external collaboration on country level. Dive into details by clicking on the dots or
Your message has successfully been sent.
Your message was not sent due to an error.
If you made any changes in Pure these will be visible here soon.